Home
/ ImmVira
/ Competitors

ImmVira Competitors and Similar CompaniesClear all

ImmVira's competitors and similar companies include Telix Pharmaceuticals, AstraZeneca, Oricell Therapeutics and Agenus.

	ImmVira ImmVira is a company that develops biopharmaceutical technology in the field of immunotherapy.	Telix Pharmaceuticals Telix Pharmaceuticals is a company developing molecularly targeted radiation products for cancer care.	AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.	Oricell Therapeutics OriCell Therapeutics (原启生物科技（上海）有限责任公司) is a biotech company specializing in tumor immunotherapy drug development.	Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
Founding Date	Founding Date 2015	Founding Date 2015	Founding Date 1999	Founding Date 2015	Founding Date 1994
Type	Type Private	Type Public	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Shenzhen Shi, CN HQ	Locations North Melbourne, AU HQ Milton, AU Sydney, AU Herstal, BE Burnaby, CA Kyoto, JP Lancy, CH see more	Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more	Locations Shanghai, CN HQ	Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US
Employees	Employees 15	Employees 415	Employees 94,300	Employees 235% increase	Employees 8174% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 4.6 b	Valuation ($) 2.7 b	Valuation ($) N/A	Valuation ($) 96.2 m
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $803.8m (FY, 2025)	Revenue (est.) $58.7b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $114.2m (FY, 2025)
Cost of goods	Cost of goods N/A	Cost of goods $356m (FY, 2025)	Cost of goods $4.9b (FY, 2025)	Cost of goods N/A	Cost of goods $1m (FY, 2025)
Gross profit	Gross profit N/A	Gross profit $449m (FY, 2025)	Gross profit $54.2b (FY, 2025)	Gross profit N/A	Gross profit $113.2m (FY, 2025)
Net income	Net income N/A	Net income ($7.1m) (FY, 2025)	Net income $10.2b (FY, 2025)	Net income N/A	Net income ($3.1m) (FY, 2025)
Funding
Latest funding round	Latest funding round $ 10m (over 5 years ago)	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 120m (almost 4 years ago)	Latest funding round N/A
Total funding raised	Total funding raised $ 90.5m	Total funding raised N/A	Total funding raised $ 1b	Total funding raised $ 162m	Total funding raised $ 171.1m